Brief communication: attitudes and preferences of long-acting injectable HIV preexposure prophylaxis among Thai adolescents and young adults

被引：0
|
作者：
Wongsethanatada, Alisa [1 ]
Songtaweesin, Wipaporn Natalie [2 ,3 ]
Wongharn, Prissana [3 ]
Moonwong, Juthamanee [3 ]
Khamthi, Sasiprapha [3 ]
Pitikawinwong, Lucksanapon [3 ]
Puthanakit, Thanyawee [3 ,4 ,5 ]
机构：
[1] Chulalongkorn Univ, Fac Med, Bangkok, Thailand
[2] Chulalongkorn Univ, Fac Med, Sch Global Hlth, Bangkok, Thailand
[3] Ctr Excellence Pediat Infect Dis & Vaccines, Bangkok, Thailand
[4] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand
[5] Chulalongkorn Univ, Fac Med, Dept Pediat, Div Infect Dis, Bangkok, Thailand
来源：
AIDS RESEARCH AND THERAPY | 2025年 / 22卷 / 01期
关键词：
HIV; PrEP; Long-acting; Youth; Adolescents; Men who have sex with men; Preference; CABOTEGRAVIR; PREVENTION;
D O I：
10.1186/s12981-025-00721-z
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
This study aimed to explore willingness to use and preference for long-acting injectable PrEP (LAI-PrEP) among Thai youth at risk of HIV. A cross-sectional study was conducted in 100 Thai youth aged 18 to 24 years attending a sexual health clinic in Bangkok, Thailand. Participants received information about oral and LAI-PrEP before completing a questionnaire. Of the 98 participants willing to use pre-exposure prophylaxis, 47 preferred the injectable form. Preference for the injectable form was higher among individuals not currently using oral pre-exposure prophylaxis, affordability and longer injection intervals were key for acceptance of long-acting injectable pre-exposure prophylaxis.
引用
收藏
页数：5
相关论文
共 50 条
  • [11] Factors Associated with Preferences for Long-Acting Injectable Antiretroviral Therapy Among Adolescents and Young People Living with HIV in South Africa
    Toska, Elona
    Zhou, Siyanai
    Chen-Charles, Jenny
    Gittings, Lesley
    Operario, Don
    Cluver, Lucie
    AIDS AND BEHAVIOR, 2023, 27 (07) : 2163 - 2175
  • [12] Who wants long-Acting injectable antiretroviral therapy? Treatment preferences among adults with HIV in Florida
    Fisk-Hoffman, Rebecca J.
    Liu, Yiyang
    Somboonwit, Charurut
    Widmeyer, Maya
    Canidate, Shantrel
    Prosperi, Mattia
    Cook, Robert L.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2024, 36 (11): : 1545 - 1554
  • [13] Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis
    Landovitz, Raphael J.
    Delany-Moretlwe, Sinead
    Fogel, Jessica M.
    Marzinke, Mark A.
    Piwowar-Manning, Estelle
    Richardson, Paul
    Halvas, Elias K.
    Mellors, John W.
    Persaud, Deborah
    Kofron, Ryan
    McCauley, Marybeth
    Rose, Scott
    Rinehart, Alex R.
    Rooney, James F.
    Adeyeye, Adeola
    Cohen, Myron S.
    Donnell, Deborah
    Hosseinipour, Mina C.
    Grinsztejn, Beatriz
    Eshleman, Susan H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (13): : 1253 - 1256
  • [14] Experiences and acceptability of Long-acting Injectable antiretroviral therapy among adolescents enrolled in the Acceptability and Feasibility of long-acting INjectable ART in Adolescents and Young-Adults (AFINAty) study in South Africa
    Atujuna, M.
    Jennings, L.
    Rousseau, E.
    Panda, R.
    Mashele, N.
    Bongo, N.
    Bekker, L. -G.
    Orrell, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 59 - 59
  • [15] A shot at equity? Addressing disparities among Black MSM in the coming era of long-acting injectable preexposure prophylaxis
    Goedel, William C.
    Nunn, Amy S.
    Chan, Philip A.
    Duncan, Dustin T.
    Biello, Katie B.
    Safren, Steven A.
    Marshall, Brandon D. L.
    AIDS, 2019, 33 (13) : 2110 - 2112
  • [16] Promotion of Long-Acting Reversible Contraception Among Adolescents and Young Adults
    Santibenchakul, Somsook
    Tschann, Mary
    Carlson, Alyssa Dee P.
    Hurwitz, Eric L.
    Salcedo, Jennifer
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2019, 64 (02) : 194 - 200
  • [17] Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis
    Ahluwalia, Amrit Kaur
    Inzaule, Seth
    Baggaley, Rachel Clare
    Vitoria, Marco
    Schaefer, Robin
    Schmidt, Heather-Marie Ann
    Rodolph, Michelle
    Giron, Amalia
    Jordan, Michael R.
    AIDS, 2022, 36 (13) : 1897 - 1898
  • [18] Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States A Cost-Effectiveness Analysis
    Neilan, Anne M.
    Landovitz, Raphael J.
    Le, Mylinh H.
    Grinsztejn, Beatriz
    Freedberg, Kenneth A.
    McCauley, Marybeth
    Wattananimitgul, Nattanicha
    Cohen, Myron S.
    Ciaranello, Andrea L.
    Clement, Meredith E.
    Reddy, Krishna P.
    Hyle, Emily P.
    Paltiel, A. David
    Walensky, Rochelle P.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (04) : 479 - +
  • [19] Brief Report: Stated Preferences for Long-Acting Injectable ART Among Mobile Men Living With HIV in Malawi: A Qualitative Study
    Thorp, Marguerite
    Phiri, Sam
    Phiri, Khumbo
    Robson, Isabella
    Mphande, Misheck
    Dovel, Kathryn
    Hoffman, Risa
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 97 (05) : e25 - e29
  • [20] Pharmacokinetics of Injectable, Long-Acting Nevirapine for HIV Prophylaxis in Breastfeeding Infants
    Cortez, John M., Jr.
    Quintero, Rafaela
    Moss, John A.
    Beliveau, Martin
    Smith, Thomas J.
    Baum, Marc M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (01) : 59 - 66
12345